Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Human Cell Atlas gets new UK funding

The project will allow researchers to define characteristics of single cell types

- PMLiVE

Can a post-Brexit UK stay aligned with Europe on clinical research?

There's still no guarantee the UK can keep in step with EU

- PMLiVE

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

Becomes the first drug approved to treat Sézary syndrome

- PMLiVE

Healthcare Comms news

Bmore creative renames, Kyne partners up with Agora and Oxford PharmaGenesis expands to Australia

- PMLiVE

ABPI hits out at ‘punitive’ UK medicines cost controls

Steep rise in charges an 'alarming signal' amid Brexit uncertainty

- PMLiVE

Pharma survey: No Brexit is the best option

But many believe a 'no deal' Brexit most likely outcome

- PMLiVE

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Firm relying on launch success in pressured US market

omnichannel

Omni-empathy

So, we’ve arrived. Our work has stepped beyond multichannel to omnichannel. We can be and in fact are everywhere, all the time. We are omni-present. We are God. Or are...

Page & Page Health

- PMLiVE

Spark sputters on haemophilia A gene therapy safety scare

Investors compare data unfavourably with BioMarin rival

- PMLiVE

Brand teams: why are some smarter than others?

It’s not for the reasons you think

Dovetail pilots new approach to joint working

Award-winning healthcare collaboration specialists Dovetail will this month pilot a new programme of workshops on improving joint working between industry and clinicians for the benefit of patients. The first meeting...

Dovetail

Rare diseases and orphan drugs: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links